{
  "retracted": false,
  "timestamp": 1554076800000,
  "updates": [
    {
      "timestamp": 1574890669320,
      "identifier": {
        "doi": "10.1016/j.ijrobp.2019.01.071"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.ijrobp.2018.01.001"
  },
  "journal": "International Journal of Radiation Oncology*Biology*Physics",
  "publisher": "Elsevier BV",
  "title": "Erratum to: Kong X-T, Nguyen NT, Choi YJ, et al. Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment. Int J Radiat Oncol Biol Phys 2018;100:1195-1203."
}
